Weight change and BMI are not prognostic markers of survival outcomes in sacituzumab govitecan therapy for mTNBC in the Polish female cohort
In this real-world Polish cohort of women with mTNBC treated with SG, neither BMI nor weight changes were prognostic indicators for survival or AE profiles. These findings underscore the necessity for identifying more reliable prognostic biomarkers in this patient population.
Authors
- Jakub Wronowicz (ORCID: https://orcid.org/0000-0002-1454-2068)
- Michał Jarząb (ORCID: https://orcid.org/0000-0002-2642-9724)
- Marek Ziobro (ORCID: https://orcid.org/0000-0002-6870-9492)
- Małgorzata Pieniążek (ORCID: https://orcid.org/0000-0001-5864-0877)
- Aleksandra Łacko
- Manuela Las‐Jankowska (ORCID: https://orcid.org/0000-0002-3970-0368)
- Anna Polakiewicz-Gilowska (ORCID: https://orcid.org/0000-0002-2175-7067)
- Mirosława Püsküllüoğlu (ORCID: https://orcid.org/0000-0002-2647-9625)
Institutions
- Nicolaus Copernicus University (PL)
- Wroclaw Medical University (PL)
- University of Bydgoszcz (PL)
- Greater Poland Cancer Center (PL)
- The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
Publication Details
- Journal
- Therapeutic Advances in Medical Oncology
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1177/17588359251363104
- Citations
- 1
- Primary Topic
- Genetic factors in colorectal cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.47